Lihe Technology (300800.SZ) plans to establish a new wholly-owned subsidiary to expand into digital and intelligent monitoring systems, among others.

date
16:29 24/09/2026
avatar
GMT Eight
Lihe Technology (300800.SZ) announced that the company plans to establish wholly-owned subsidiaries in Shanghai, Shantou City, Guangdong Province, and Hechi City, Guangxi Zhuang Autonomous Region, respectively. The newly established subsidiaries in Shantou City, Guangdong Province, and Hechi City, Guangxi Zhuang Autonomous Region, will focus on deploying intelligent sampling terminals, AI water quality monitoring systems, and full-process control platforms as core equipment, promoting a digital and intelligent monitoring system featuring "intelligent sampling + 'lights-out laboratory' + unified data platform." The newly established subsidiary in Guangdong Province has a registered capital of 10 million yuan, and the newly established subsidiary in Guangxi Zhuang Autonomous Region has a registered capital of 5 million yuan.
Lihe Technology (300800.SZ) announced that the company plans to establish wholly-owned subsidiaries in Shanghai, Shantou City, Guangdong Province, and Hechi City, Guangxi Zhuang Autonomous Region, respectively. The newly established subsidiaries in Shantou City, Guangdong Province, and Hechi City, Guangxi Zhuang Autonomous Region, will focus on deploying intelligent sampling terminals, AI water quality monitoring systems, and full-process management and control platforms as core equipment, promoting a digital and intelligent monitoring system featuring "intelligent sampling + 'dark factory laboratory' + unified data platform." The newly established subsidiary in Guangdong Province has a registered capital of 10 million yuan, and the newly established subsidiary in Guangxi Zhuang Autonomous Region has a registered capital of 5 million yuan. The newly established subsidiary in Shanghai will focus on health impact assessment of emerging pollutants, screening and assessment of endocrine toxicity of chemicals, and the research, development, and production of supporting cell and protein products. Its registered capital is 3 million yuan.